Third Harmonic Bio
chronic urticaria disease overview out there it a horrible world for urticaria patients | Third Harmonic Bio
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
5 of 20
Similar slides by Third Harmonic Bio
See diffirences between slides (animation)
IPO
September 2022
out there it a horrible world | Third Harmonic Bio
Related slides by other companies
Alkermes
Investor Presentation
January 2023
and oral treatment option for adults with schizophrenia or bipolar i disorder | Alkermes
Matinas BioPharma
Investor Presentation
March 2024
mat expanded access compassionate use program demonstrated efficacy in treatment of patients with limited treatment options | Matinas BioPharma
AstraZeneca
Investor Conference
January 2023
positioned to lead in million | AstraZeneca
BenevolentAI
Investor Presentation
October 2022
ben is being developed to address key unmet needs in the treatment of atopic dermatitis atopic dermatitis treatment paradigm ben development is targeting against both itch and in with potential disease modifying effects improved safety pro suitable for chronic use with no irritancy on application positioning potential to displace ineffective and poorly tolerated second line treatment for chronic use in adults and potential use in a subset of line patients where rapid itch resolution is key and in the severe patient population as an adjunct treatment option | BenevolentAI
Other recent decks by Third Harmonic Bio
See all presentations (2 decks)
IPO
September 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io